BIO-TECHNE Corp (TECH) closed fiscal year 2025 with a gross margin of 64.8 % and a net margin of 6.0 %.
BIO-TECHNE Corp (TECH) closed fiscal year 2025 with a gross margin of 64.8 % and a net margin of 6.0 %. The same year shows an EBITDA margin of 17.4 % and an EBIT margin of 8.4 %. The free cash flow margin was 21.0 %. Against the previous year the gross margin moved −1.6 pp and the net margin −8.5 pp. Across the period the gross margin ranges between 64.8 % in 2025 and 79.6 % in 2010. The series covers 17 fiscal years, from 2009 to 2025. Margins are expressed as a percentage of net revenue and are derived from the same figures as the income statement, taken from as-reported SEC EDGAR filings, with no restatements or adjustments of our own.
Fiscal year end: June
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin (%) | 78.81 % | 79.60 % | 77.57 % | 74.96 % | 74.41 % | 70.27 % | 67.94 % | 67.46 % | 66.53 % | 67.21 % | 66.31 % | 65.41 % | 67.97 % | 68.42 % | 67.72 % | 66.41 % | 64.80 % |
| EBITDA margin (%) | 60.07 % | 61.13 % | 59.23 % | 56.80 % | 4.02 % | 50.01 % | 40.74 % | 38.75 % | 32.08 % | 31.20 % | 31.50 % | 32.51 % | 34.91 % | 35.97 % | 35.73 % | 27.47 % | 17.40 % |
| EBIT margin (%) | 57.12 % | 58.10 % | 56.23 % | 52.84 % | 0.05 % | 44.65 % | 32.51 % | 30.18 % | 21.42 % | 21.18 % | 20.55 % | 21.31 % | 25.49 % | 26.83 % | 26.30 % | 17.83 % | 8.38 % |
| Net margin (%) | 39.87 % | 40.80 % | 38.73 % | 35.71 % | 36.24 % | 31.01 % | 23.82 % | 20.94 % | 13.51 % | 19.62 % | 13.46 % | 31.04 % | 15.08 % | 24.61 % | 25.10 % | 14.50 % | 6.02 % |
| FCF margin (%) | 39.69 % | 39.63 % | 42.61 % | 38.38 % | 32.56 % | 34.36 % | 26.41 % | 25.50 % | 22.83 % | 23.24 % | 21.88 % | 20.78 % | 33.07 % | 25.36 % | 19.02 % | 20.37 % | 21.03 % |
